XTalks

SEPTEMBER 14, 2022

Daxxify was FDA-approved for similar cosmetic purposes as Botox and other neuromodulators like Dysport and Xeomin. One of the first options made available for such purposes was Botox from Allergan, brought to health practitioners’ offices in 1989. A Novel Botox Competitor.

Botox 98

Botox FDA Approval Cosmetics Clinical Trials 98

XTalks

JANUARY 20, 2025

From Bristol-Myers Squibbs monumental acquisition of Celgene to Pfizers recent purchase of Seagen, these deals illustrate the strategies and ambitions driving innovation in life sciences. Following the merger, Actavis rebranded itself as Allergan, leveraging the strong recognition of Allergans brand.

Marketing 104

Marketing Botox Life Science Pharma Companies 104

The Pharma Data

AUGUST 1, 2021

Global Botox Therapeutic net revenues were $603 million, an increase of over 100.0 Global Botox Cosmetic net revenues were $584 million, an increase of over 100.0 AbbVie also presented real-world data on the role of Botox in combination with CGRP mAbs for Chronic Migraine prevention. percent on a reported basis, or 29.6

Botox 52

Botox Cosmetics Trials Clinical Trials 52

XTalks

OCTOBER 4, 2024

Botulinum toxin (Botox) injections can temporarily reduce muscle spasticity by tightening muscles in specific areas. Muscle relaxants (e.g., baclofen, diazepam) can help reduce spasticity and are used to help relax muscles. Anticonvulsants are used to control seizures, which can be common in individuals with cerebral palsy.

Genetics 52

Genetics Botox Research Development 52

XTalks

AUGUST 2, 2023

percent increase since 2021, predominantly due to Botox sales for therapeutic uses. 2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. Botox is also used as therapeutic treatments for neck spasms, excessive sweating, lazy eyes and migraines.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

JULY 4, 2024

The pharma industry is poised for significant transformations in 2024, driven by groundbreaking drugs that have set new benchmarks in the industry. This blog delves into the top 30 drugs to watch in 2024, leveraging insights from their sales performance in 2023.

Sales 40

Sales Drugs FDA Approval Marketing 40

XTalks

JUNE 17, 2024

Among the most widely sought-after options are botulinum toxin injections, commonly referred to as Botox or Dysport. RELATED: Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics – Xtalks Life Science Podcast Ep.

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52